Elahere (mirvetuximab soravtansina) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento
swki.me/vRkH9OT7
#infarmed #medicamentos #financiamentopublico #elahere
swki.me/vRkH9OT7
#infarmed #medicamentos #financiamentopublico #elahere
September 23, 2026 at 1:58 PM
Elahere (mirvetuximab soravtansina) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento
swki.me/vRkH9OT7
#infarmed #medicamentos #financiamentopublico #elahere
swki.me/vRkH9OT7
#infarmed #medicamentos #financiamentopublico #elahere
NHS Rolls Out New Ovarian Cancer Treatment After 20 Years
The NHS in England has started using mirvetuximab soravtansine. called Elahere, for platinum-resistant ovarian cancer in adults positive for FRa protein after one to three prior therapies.
The NHS in England has started using mirvetuximab soravtansine. called Elahere, for platinum-resistant ovarian cancer in adults positive for FRa protein after one to three prior therapies.
June 4, 2026 at 11:53 AM
NHS Rolls Out New Ovarian Cancer Treatment After 20 Years
The NHS in England has started using mirvetuximab soravtansine. called Elahere, for platinum-resistant ovarian cancer in adults positive for FRa protein after one to three prior therapies.
The NHS in England has started using mirvetuximab soravtansine. called Elahere, for platinum-resistant ovarian cancer in adults positive for FRa protein after one to three prior therapies.
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
Ovarian cancer drug approved for NHS use will prolong lives
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
tcnv.link
June 11, 2026 at 1:13 PM
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
My mom has platinum-resistant stage 4 ovarian cancer and Elahere from AbbVie is keeping her here with us. It costs $104,000 a dose before insurance, $4k after. It is worth every damn penny. And we owe it to science and the researchers funded by orgs like the NIH. Also: FDT.
Has any new drug saved your life or the life of someone you know? If so, you can thank the NIH, which Trump and Musk are illegally destroying, in violation both of the law creating the NIH, and appropriations laws telling NIH what money to spend and how
A pie graph worth keeping in mind as the NIH budget plummets jamanetwork.com/journals/jam... for 356 new FDA drugs approved
March 24, 2025 at 2:27 AM
My mom has platinum-resistant stage 4 ovarian cancer and Elahere from AbbVie is keeping her here with us. It costs $104,000 a dose before insurance, $4k after. It is worth every damn penny. And we owe it to science and the researchers funded by orgs like the NIH. Also: FDT.
The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, Elahere, for patients with a hard-to-treat form of ovarian cancer.
British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy
The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, Elahere, for patients with a hard-to-treat form of ovarian cancer.
reut.rs
June 3, 2026 at 11:45 PM
The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, Elahere, for patients with a hard-to-treat form of ovarian cancer.
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years
Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant ovarian cancer to be approved for more than 20 years.
Ovarian is the 18th most common type of cancer globally, affecting more than 300,000 women a year. More than three-quarters of patients are diagnosed at an advanced stage, making it harder to treat. Continue reading...
www.theguardian.com
June 3, 2026 at 11:07 PM
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
My first journo request on here: For a story, I'm looking to speak with people with cancer who received treatment with an antibody-drug conjugate drug (Enhertu, Kadcyla, Elahere and the like) and experienced meaningful benefits, in whatever form🧪
September 21, 2023 at 10:28 PM
My first journo request on here: For a story, I'm looking to speak with people with cancer who received treatment with an antibody-drug conjugate drug (Enhertu, Kadcyla, Elahere and the like) and experienced meaningful benefits, in whatever form🧪
AbbVie to launch ovarian cancer drug in UK at the same list price as US reut.rs/4nkZStm
AbbVie to launch ovarian cancer drug in UK at the same list price as US
AbbVie said on Monday it would launch its ovarian cancer drug Elahere in the U.K. at a list price equal to that in the U.S.
reut.rs
September 29, 2025 at 1:15 PM
AbbVie to launch ovarian cancer drug in UK at the same list price as US reut.rs/4nkZStm
British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy reut.rs/4avd2Q3
British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy
The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, Elahere, for patients with a hard-to-treat form of ovarian cancer.
reut.rs
June 4, 2026 at 4:50 AM
British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy reut.rs/4avd2Q3
Did she take Elahere, by chance?
September 23, 2025 at 9:45 PM
Did she take Elahere, by chance?
I’m on Elahere+Avastin. Elahere has its own challenges but Avastin gave me high BP and the bloody noses. Also changed my voice.
November 15, 2024 at 3:54 AM
I’m on Elahere+Avastin. Elahere has its own challenges but Avastin gave me high BP and the bloody noses. Also changed my voice.
2/2
Liek Elahere jej síce účinkuje už päť mesiacov, no stojí takmer 9-tisíc eur na tri týždne a na Slovensku nie je kategorizovaný, čiže poisťovňa ho štandardne neuhrádza. (N)
Liek Elahere jej síce účinkuje už päť mesiacov, no stojí takmer 9-tisíc eur na tri týždne a na Slovensku nie je kategorizovaný, čiže poisťovňa ho štandardne neuhrádza. (N)
August 22, 2026 at 3:45 AM
2/2
Liek Elahere jej síce účinkuje už päť mesiacov, no stojí takmer 9-tisíc eur na tri týždne a na Slovensku nie je kategorizovaný, čiže poisťovňa ho štandardne neuhrádza. (N)
Liek Elahere jej síce účinkuje už päť mesiacov, no stojí takmer 9-tisíc eur na tri týždne a na Slovensku nie je kategorizovaný, čiže poisťovňa ho štandardne neuhrádza. (N)
Ovarian cancer tidbit: A new combo therapy shrank tumors in 63% of patients (with high folate receptor alpha, a protein on tumor cells). Imagine 6 of 10 people seeing a benefit. Phase 2, but promising!
AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinu
New results from the Phase 2 IMGN853-0420 trial indicate that the drug mirvetuximab soravtansine-gynx (ELAHERE®) when combined with carboplatin, and then continued as a single treatment, is effective
www.biospace.com
April 14, 2026 at 2:04 AM
Ovarian cancer tidbit: A new combo therapy shrank tumors in 63% of patients (with high folate receptor alpha, a protein on tumor cells). Imagine 6 of 10 people seeing a benefit. Phase 2, but promising!
Thank you. I will be fine thanks to a drug called Elahere. Wish I could say the same about my husband 😞
May 28, 2026 at 12:37 PM
Thank you. I will be fine thanks to a drug called Elahere. Wish I could say the same about my husband 😞
Ovarian cancer drug approved for NHS use will prolong lives
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
Ovarian cancer drug approved for NHS use will prolong lives
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
fllics.com
June 11, 2026 at 12:06 PM
Ovarian cancer drug approved for NHS use will prolong lives
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
#oncology #resistantovariancancer #ovariancancer #mirvetuximabsoravtansine #Elahere #AbbVie #antibodydrugconjugate #ADC #epithelialovariancancer #fallopiantubecancer #primaryperitonealcancer #folatereceptoralphapositiveovariancancer #MIRASOLstudy #CancerDrugsFund
zurl.co/3c2Cw
zurl.co/3c2Cw
First new NHS treatment in over 20 years recommended for women with resistant ovarian cancer
NICE recommends new treatment for resistant ovarian cancer
www.nice.org.uk
June 5, 2026 at 9:06 AM
Second Elahere treatment accomplished this morning with no adverse reactions, but we learned that one of my regular infusion nurses has family in Jamaica. All my hopes for the safety and well-being of those in the storm's path. ❤️🙏
October 28, 2025 at 2:23 AM
Second Elahere treatment accomplished this morning with no adverse reactions, but we learned that one of my regular infusion nurses has family in Jamaica. All my hopes for the safety and well-being of those in the storm's path. ❤️🙏
In The Chair, mildly tripping on Bendadryl through the IV and being told I am the very first person at this facility to receive this very new medication, Elahere, yay. 👀
Joking with the nurses about letting them know if I start to swell up like a puffer fish. So far so good.
Joking with the nurses about letting them know if I start to swell up like a puffer fish. So far so good.
a puffer fish is swimming in the water and looking at the camera
Alt: a puffer fish is swimming in the water and looking at the camera
media.tenor.com
October 6, 2025 at 6:17 PM
In The Chair, mildly tripping on Bendadryl through the IV and being told I am the very first person at this facility to receive this very new medication, Elahere, yay. 👀
Joking with the nurses about letting them know if I start to swell up like a puffer fish. So far so good.
Joking with the nurses about letting them know if I start to swell up like a puffer fish. So far so good.
✅ Anvisa aprova medicamento para câncer de ovário resistente à quimio
💊 Elahere, da AbbVie, atua em pacientes com receptor FRα e já tem aval da FDA nos Estados Unidos.
⬇️ Leia no Poder360:
www.poder360.com.br/poder-saude/...
💊 Elahere, da AbbVie, atua em pacientes com receptor FRα e já tem aval da FDA nos Estados Unidos.
⬇️ Leia no Poder360:
www.poder360.com.br/poder-saude/...
Anvisa aprova medicamento para câncer de ovário resistente à quimio
Elahere, da AbbVie, atua em pacientes com receptor FRα e já tem aval da FDA nos Estados Unidos. Leia no Poder360.
www.poder360.com.br
September 4, 2025 at 1:16 AM
✅ Anvisa aprova medicamento para câncer de ovário resistente à quimio
💊 Elahere, da AbbVie, atua em pacientes com receptor FRα e já tem aval da FDA nos Estados Unidos.
⬇️ Leia no Poder360:
www.poder360.com.br/poder-saude/...
💊 Elahere, da AbbVie, atua em pacientes com receptor FRα e já tem aval da FDA nos Estados Unidos.
⬇️ Leia no Poder360:
www.poder360.com.br/poder-saude/...
A new drug for ovarian cancer will be rolled out on the NHS. Elahere is known as a “biological missile” because it delivers chemotherapy drugs directly to cancerous tissue rather than the whole body, reducing debilitating side-effects and adding several months to patients’ lives.
June 4, 2026 at 12:02 PM
A new drug for ovarian cancer will be rolled out on the NHS. Elahere is known as a “biological missile” because it delivers chemotherapy drugs directly to cancerous tissue rather than the whole body, reducing debilitating side-effects and adding several months to patients’ lives.
Stage 4 ovarian cancer. Currently on Elahere + Avastin.
November 14, 2024 at 4:41 PM
Stage 4 ovarian cancer. Currently on Elahere + Avastin.
